NutriBand (NTRB) secures patent for abuse deterrent technology

NutriBand Inc. (NASDAQ: NTRB) announced the expected issuance of a U.S. patent for its Aversa™ abuse deterrent technology. The United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for the patent application titled "Abuse and Misuse Deterrent Transdermal Systems" on February 3, 2025.

The Notice of Allowance is a significant milestone for NutriBand, indicating that the USPTO intends to grant a patent once administrative procedures are completed. The technology covered by the application includes a transdermal system designed to deter the abuse and misuse of active substances.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• iQSTEL restructures corporate entities in internal realignment
• Faraday Future registers up to 62M shares for resale